Trial Details
RECRUITINGBasic Information
| Clinical ID | c575 |
|---|---|
| Identifier | NCT06405087 |
| Trial Title | A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Vedolizumab SC|OTHER: No Intervention |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Tokyo |
| Country/Region | Japan |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-27 |
|---|---|
| Primary Completion Date | 2032-01-26 |
| Completion Date | 2032-01-26 |